TABLE 3.
HSV-1 and HSV-2 gG type-specific ELISA index values and Western blot analysis results by visit for women whose antibody status reverted from positive to negative by ELISAa
| Patient ID and virus | Index value/Western blot resultd at visit:
|
|||
|---|---|---|---|---|
| Baseline | 4 mo | 8 mo | 12 mo | |
| HSV-1 | ||||
| 1 | 1.23/0 | 0.96/0 | 0.59/0 | 0.46/0 |
| 2 | 1.23/0 | 0.87/0 | 0.87/0 | 2.08/0 |
| 3b | 1.74/1 | 0.54/0 | 0.80/0 | 0.84/1 |
| 4 | 1.53/0 | 1.43/0 | 1.24/0 | 0.64/0 |
| 5c | 3.30/1 | 3.79/1 | 3.66/1 | 0.13/0 |
| 6 | 0.16/0 | 0.60/0 | 1.18/0 | 0.42/0 |
| 7 | 0.91/0 | 0.93/1 | 1.26/1 | 0.83/1 |
| 8 | 1.55/0 | 0.86/0 | 0.68/0 | 0.49/0 |
| 9 | 0.86/0 | 1.19/0 | 0.78/0 | 0.70/0 |
| 10 | 1.43/0 | 0.78/0 | 0.78/0 | 0.85/0 |
| 11 | 1.26/1 | 0.72/1 | 1.21/1 | 0.97/1 |
| HSV-2 | ||||
| 1 | 0.22/1 | 2.52/1 | 0.60/1 | 0.47/1 |
| 2 | 1.16/0 | 1.07/0 | 0.75/0 | 1.11/0 |
a
Data for women who made four visits and hence had four serum samples.
b
Interpretation of the Western blot results indicated that samples from the baseline and 12-month visits were not from the same subject as those from the 4- and 8-month visits.
c
Interpretation of the western blot results indicated that the sample from the 12-month visit was not from the same subject as those from the baseline and the 4- and 8-month visits.
d
Western blot results were as follows: 0, antibody to neither HSV-1 or HSV-2; 1, antibody to HSV-1; 2, antibody to HSV-2.